Nomura Funds Ireland plc - American Century Advanced Medical Impact Equity Fund

101,61
-0,15%
07/12/2022
Riesgo
6/7
ISIN
IE00BMH6QF13
Categoría
Patrimonio
5,9M€
Rentabilidad YTD
-5,28%

Estrategia de inversión

The investment objective of the Sub-Fund is to achieve long-term capital growth through investment in an actively managed portfolio of equity securities of companies engaged in the health care sector. The Sub-Fund will invest, under normal market conditions, primarily in Equity and Equity-Related Securities of companies engaged in the health care sector, which are listed or traded on a Recognised Exchange and which companies may be selected from the Index. The Sub-Fund will consist of health care companies, which are companies classified in the health care category as per the Global Industry Classification Standard (GICS®) and / or those companies that otherwise, in the opinion of the Investment Manager, promote the philosophy of healthy lives and well-being for all and are innovative and capable of sustainable business development (“Health Care Companies”), as further set out in the “Investment Strategy” below.

Comisiones

Management Fee
1.80%
On Going Charge
1.95%
Total Expense Ratio
1.95%

Otras clases

Nombre ISIN Comisión
Nomura Funds Ireland plc - American Century Advanced Medical Impact Equity Fund I USD Acc IE00BMH6QM89 0,90 %
Nomura Funds Ireland plc - American Century Advanced Medical Impact Equity Fund F USD Acc IE00BMH6QJ50 0,45 %
Nomura Funds Ireland plc - American Century Advanced Medical Impact Equity Fund A USD Acc IE00BMH6QF13 1,80 %
Nomura Funds Ireland plc - American Century Advanced Medical Impact Equity Fund A EUR Acc IE00BMH6QG20 1,80 %

Rentabilidad por períodos

Período
Acumulada
Anualizada
Año actual
-5,28% -
30 días
-0,47% -
6 meses
8,57% -
12 meses
-1,13% -

Rentabilidad por trimestres

Año T1 T2 T3 T4
2021 - - 11,30% -0,44% 5,30%
2022 - -6,50% -13,45% -0,65% -

Rentabilidad mensual

Rentabilidad de los últimos 12 meses

Categoría

Top Nomura Funds Ireland plc - American Century Advanced Medical Impact Equity Fund frente a su categoría

Documentos

Documento
Última actualización
Prospectus
03/12/2022
SemiannualReport
24/11/2022
Key Investor Information Document (KIID)
11/06/2022
AnnualReport
24/11/2022
Supplement
10/04/2021

Divisas

Materias primas

Volver arriba